8SWE

FGFR2 Kinase Domain Bound to Reversible Inhibitor Cmpd 3

8SWE の概要

• エントリーDOI: 10.2210/pdb8swe/pdb
• 分子名称: Fibroblast growth factor receptor 2, GLYCEROL, GLUTATHIONE, ... (5 entities in total)
• 機能のキーワード: inhibitor kinase, oncoprotein
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 73717.83

構造登録者

Valverde, R.,Foster, L. (登録日: 2023-05-18, 公開日: 2024-02-14)

• 主引用文献: Schonherr, H.,Ayaz, P.,Taylor, A.M.,Casaletto, J.B.,Toure, B.B.,Moustakas, D.T.,Hudson, B.M.,Valverde, R.,Zhao, S.,O'Hearn, P.J.,Foster, L.,Sharon, D.A.,Garfinkle, S.,Giordanetto, F.,Lescarbeau, A.,Kurukulasuriya, R.,Gerami-Moayed, N.,Maglic, D.,Bruderek, K.,Naik, G.,Gunaydin, H.,Mader, M.M.,Boezio, A.A.,McLean, T.H.,Chen, R.,Wang, Y.,Shaw, D.E.,Watters, J.,Bergstrom, D.A.; Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2.; Proc.Natl.Acad.Sci.USA, 121:e2317756121-e2317756121, 2024; PubMed: 38300868; DOI: 10.1073/pnas.2317756121

実験手法

X-RAY DIFFRACTION (2.24 Å)